Basic Information
| RNALocate ID: | RLID:11004024 |
| RNA Symbol: | hsa-miR-574-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-574-5p |
| RNA ID: | miRBase:MIMAT0004795 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002683 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002684 | Nucleus | LAC cell line (A549) | 32231562 |
| RLID:11004022 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11004023 | Exosome | Breast milk | 22211110 |
| RLID:11004025 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11004026 | Extracellular vesicle | Colon cancer cell line (LIM1863) | 25330373 |
| RLID:11004027 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000208 | Exosome | Breast milk|Seminal fluid | |
| RLID-D:11000694 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-574-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-61361 |
| MNDR | hsa-miR-574-5p | B cell lymphoma of malt type | MNDR-E-MI-61362 |
| MNDR | hsa-miR-574-5p | Lymphoma | MNDR-E-MI-61363 |
| MNDR | hsa-miR-574-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-61364 |
| MNDR | hsa-miR-574-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-61365 |
| MNDR | hsa-miR-574-5p | Prostate cancer | MNDR-E-MI-61366 |
| MNDR | hsa-miR-574-5p | Gastric cancer | MNDR-E-MI-61367 |
| MNDR | hsa-miR-574-5p | Alzheimer disease | MNDR-E-MI-61368 |
| MNDR | hsa-miR-574-5p | Intracranial aneurysm | MNDR-E-MI-61369 |
| MNDR | hsa-miR-574-5p | Seizures | MNDR-E-MI-61370 |
| MNDR | hsa-miR-574-5p | Moyamoya disease | MNDR-E-MI-61371 |
| MNDR | hsa-miR-574-5p | Lung cancer | MNDR-E-MI-61372 |
| MNDR | hsa-miR-574-5p | Parkinson disease | MNDR-E-MI-61373 |
| MNDR | hsa-miR-574-5p | Breast cancer | MNDR-E-MI-61374 |
| MNDR | hsa-miR-574-5p | Neuroendocrine neoplasia | MNDR-E-MI-61375 |
| MNDR | hsa-miR-574-5p | Pituitary neoplasms | MNDR-E-MI-61376 |
| MNDR | hsa-miR-574-5p | Pancreatic cancer | MNDR-E-MI-61377 |
| MNDR | hsa-miR-574-5p | Rectum adenocarcinoma | MNDR-E-MI-61378 |
| MNDR | hsa-miR-574-5p | Colon adenocarcinoma | MNDR-E-MI-61379 |
| MNDR | hsa-miR-574-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-61380 |
| MNDR | hsa-miR-574-5p | Familial ovarian cancer | MNDR-E-MI-61381 |
| MNDR | hsa-miR-574-5p | Acromegaly | MNDR-E-MI-61382 |
| MNDR | hsa-miR-574-5p | Prostate adenocarcinoma | MNDR-E-MI-61383 |
| MNDR | hsa-miR-574-5p | Glioblastoma | MNDR-E-MI-61384 |
| MNDR | hsa-miR-574-5p | Astrocytoma | MNDR-E-MI-61385 |
| MNDR | hsa-miR-574-5p | Malignant glioma | MNDR-E-MI-61386 |
| MNDR | hsa-miR-574-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-61387 |
| MNDR | hsa-miR-574-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-61388 |
| MNDR | hsa-miR-574-5p | Liposarcoma | MNDR-E-MI-61389 |
| MNDR | hsa-miR-574-5p | Coronary artery disease | MNDR-E-MI-61390 |
| MNDR | hsa-miR-574-5p | Middle cerebral artery infarction | MNDR-E-MI-61391 |
| MNDR | hsa-miR-574-5p | Pituitary adenoma | MNDR-E-MI-61392 |
| MNDR | hsa-miR-574-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-61393 |
| MNDR | hsa-miR-574-5p | Lung adenocarcinoma | MNDR-E-MI-61394 |
| MNDR | hsa-miR-574-5p | Pancreatic adenocarcinoma | MNDR-E-MI-61395 |
| MNDR | hsa-miR-574-5p | Biliary tract cancer | MNDR-E-MI-61396 |
| MNDR | hsa-miR-574-5p | Cholangiocarcinoma | MNDR-E-MI-61397 |
| MNDR | hsa-miR-574-5p | Lung small cell carcinoma | MNDR-E-MI-61398 |
| MNDR | hsa-miR-574-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-61399 |
| MNDR | hsa-miR-574-5p | Familiar ovarian carcinoma | MNDR-E-MI-61400 |
| MNDR | hsa-miR-574-5p | B-cell lymphoma | MNDR-E-MI-61401 |
| MNDR | hsa-miR-574-5p | Hodgkin lymphoma | MNDR-E-MI-61402 |
| MNDR | hsa-miR-574-5p | Colorectal cancer | MNDR-E-MI-61403 |
| MNDR | hsa-miR-574-5p | Nasopharynx carcinoma | MNDR-E-MI-61404 |
| MNDR | hsa-miR-574-5p | Nasopharyngeal cancer | MNDR-E-MI-61405 |
| MNDR | hsa-miR-574-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-61406 |
| MNDR | hsa-miR-574-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-61407 |
| MNDR | hsa-miR-574-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-61408 |
| MNDR | hsa-miR-574-5p | Stroke lacunar | MNDR-E-MI-61409 |
| MNDR | hsa-miR-574-5p | Breast cancer her3+ negative | MNDR-E-MI-61410 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | EZH1 | Homo sapiens | RR00518696 |
TOP